导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 6.17% | 1138/4773 |
| 近一周 | -1.05% | 1588/5465 |
| 近一月 | -3.52% | 2593/5421 |
| 近一季 | -8.25% | 3189/5231 |
| 近半年 | -3.29% | 2452/4920 |
| 近一年 | 11.08% | 1052/4394 |
| 近两年 | 85.68% | 765/2954 |
| 近三年 | 48.45% | 592/2253 |
| 成立以来 | 115.89% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.27% 986/4961 |
20.18% 1247/5312 |
- - |
- - |
| 2025 | 34.61% 1031/4813 |
2.95% 1232/3635 |
2.29% 1678/4076 |
26.16% 1358/4524 |
1.32% 1420/4813 |
| 2024 | 9.06% 1498/3463 |
-2.57% 1382/2808 |
-5.09% 1642/3014 |
17.15% 1259/3129 |
0.68% 1181/3463 |
| 2023 | -4.57% 686/2656 |
8.23% 480/2280 |
-3.74% 886/2385 |
-3.98% 1031/2515 |
-4.60% 1111/2655 |
| 2022 | -17.29% 570/2207 |
-13.60% 794/1919 |
3.45% 1150/2016 |
-10.17% 359/2113 |
3.02% 784/2208 |
| 2021 | 25.13% 113/1822 |
-0.16% 335/1255 |
12.41% 335/1330 |
6.82% 209/1466 |
4.37% 336/1822 |
| 2020 | 33.61% 453/1250 |
-5.48% 424/1028 |
19.59% 296/1067 |
11.98% 412/1164 |
5.56% 780/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 鹏华中证500ETF VS. 长安沪深300非周期A(740101) |